Results 71 to 80 of about 3,889 (160)
Impact of a Neurogenic Dysphagia Outpatient Clinic on Diagnosis, Treatment, and Nutrition
European Journal of Neurology, Volume 33, Issue 3, March 2026.This retrospective study analyzed 255 patients evaluated at a university‐led neurogenic dysphagia outpatient clinic between 2021 and 2023. It assessed diagnostic, therapeutic, and nutritional outcomes using FEES‐based swallowing evaluations. The findings show that structured outpatient dysphagia care significantly enhances diagnostic precision, guides ...
Bendix Labeit +7 more
wiley +1 more source
Necrotizing autoimmune myopathy
, 2011 PURPOSE OF REVIEW: Necrotizing autoimmune myopathy (NAM) is a relatively newly recognized subgroup of idiopathic inflammatory myopathies, which despite diverse causes, have the common histopathological features of myocyte necrosis without significant ...
Liang, C. +3 more
core +1 more source
European Journal of Neurology, Volume 33, Issue 3, March 2026.ABSTRACT Background Monoclonal gammopathy‐associated myopathies (MGAMs) include light chain (AL) amyloid myopathy, sporadic late‐onset nemaline myopathy (SLONM), and vacuolar myopathy with monoclonal gammopathy and stiffness (VAMMGAS). These subtypes usually occur separately, although rare overlap has been described. We report a patient with monoclonal
Felipe J. S. Jones +4 more
wiley +1 more source
Two Cases of Statin-Induced Immune-Mediated Necrotizing Myopathy: A Rare Side Effect of Statins
Statins are effective drugs for lowering cholesterol and reducing cardiovascular risk. Rarely, they can trigger autoimmune myopathies like immune-mediated necrotizing myopathy (IMNM), associated with anti-HMGCR antibodies.
Clara Fernandez Peña +2 more
core +1 more source
Autophagy markers LC3 and p62 accumulate in immune‐mediated necrotizing myopathy
, 2019 Introduction: The molecular mechanism of immune-mediated necrotizing myopathy (IMNM) remains unknown. Autophagy impairment, described in autoimmune diseases, is a key process in myofibre protein degradation flux and muscle integrity, and has not been ...
Anna, Lia +11 more
core +1 more source
Immune-mediated Necrotizing Myopathy in a Patient with Microscopic Polyangiitis
Internal MedicineWe herein report a case of immune-mediated necrotizing myopathy (IMNM) in a patient with microscopic polyangiitis (MPA). A 77-year-old Japanese woman presented with a 2-day history of proximal muscle weakness and myalgia, with elevated serum creatinine kinase (CK) levels.
Umemoto, Daichi +8 more
openaire +2 more sources
Statin-Associated Autoimmune Myopathy: Current Perspectives
, 2020 Eleni Tiniakou Johns Hopkins University School of Medicine, Department of Medicine, Division of Rheumatology, Baltimore, MD, USACorrespondence: Eleni TiniakouJohns Hopkins University School of Medicine, 5200 Eastern Avenue, Mason Lord, Center Tower ...
Tiniakou E
core
Immune-Mediated Necrotizing Myopathy in Association with Statin Exposure
Statins are first-line therapy for hyperlipidemia and are widely prescribed in primary care. Although generally safe, they carry rare but serious risks that must be considered on an individual basis.
Rossi, Phebie +2 more
core +1 more source
Immune-mediated necrotizing myopathy (IMNM) is a rare subtype of idiopathic inflammatory myopathy that is characterized by severe subacute proximal weakness, myofiber necrosis, and significantly elevated serum creatine kinase.
Semlil, Lamyaa +6 more
core +1 more source
Immune-mediated necrotizing myopathy [PDF]
Neurologie pro praxi, 2017 Tomáš Kalous, Josef Zámečník
openaire +1 more source